생체 임플란트 시장 : 이식편별, 시술 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2026-2033년)

Biological Implants Market size was valued at US$ 9,560.3 Million in 2025, expanding at a CAGR of 6.8% from 2026 to 2033.

Biological Implants are the medical devices which are surgically implanted into the body and are made from natural human tissue, biological materials of animal origin, or bioengineered biological materials. In contrast to synthetic implants, biological implants actively interact with physiological processes of the human body, facilitating tissue regeneration, cellular integration and biocompatibility. Bone grafts, biological heart valves, ADMs, collagen-based scaffolds, biologic meshes, corneal grafts, tendons/ligaments grafts, tissue engineered implants are typical examples of biological implants.

The market witness's stable growth due to increasing prevalence of musculoskeletal disorders, cardiovascular diseases, trauma, chronic wounds, and degenerative diseases. Increasing demand for regenerative medicine, innovations in tissue engineering, active development of organ and tissue transplantations, and popularity of biocompatible implants are additional factors which are propelling market growth. Advancements in extracellular matrix technologies, stem cell technology, decellularization techniques, 3D printing, and bioengineering of tissue scaffolds provide better performance of biological implants. Moreover, higher health care spending and more access to advanced surgical techniques have been contributing to the growth in the use of biological implants in orthopedic, cardiovascular, reconstructive, dental, ocular, and wound healing applications.

Biological Implants Market- Market Dynamics

Rising Burden of Musculoskeletal Disorders and Increasing Healthcare Expenditure Driving Market Growth

The growing number of orthopedic disorders, cardiovascular diseases, chronic wounds, burns, sports injuries, and reconstructive surgeries is greatly fueling the need for biological implants in the global market. According to the WHO, nearly 1.71 billion people suffering from musculoskeletal disorders all over the world. They are the major reasons of disabilities; low back pain remains the major factor of disability in 160 countries, which promotes the usage of biological implants. Being highly biocompatible and able to promote tissue regeneration and having fewer risks of chronic inflammation compared to synthetic implants, biological implants are preferred in various types of surgeries. Moreover, the fast-growing population of older adults increases the demand of the market, since they are at higher risk of osteoporosis, osteoarthritis, degenerative disorders of the spine, heart valve diseases, and chronic wound problems. Finally, the increasing tendency towards the minimally invasive procedures is fostering the need of biological implants because of their better tissue integration, quicker recovery, low risk of infection, and revision rate.

Rising health care expenditures along with innovations in the field of regenerative medicine will add impetus to the market growth. According to the Eurostat, the expenditure on health care in the European Union was recorded at €1.72 trillion in 2023, which accounted for 10.0% of EU GDP, while per capita expenditure on health care rose from €2,668 in 2014 to €3,835 in 2023, indicating an increase of 43.7%. These expenditures are building a robust infrastructure in the sector and providing access to advanced implant technologies. In parallel, the NIH continues to emphasize research into regenerative medicine and tissue engineering to promote the development of biomaterials, stem cell technology, and tissue engineering for tissue replacement and regeneration. Innovations in the areas of tissue preservation, sterilization, donor tissue preparation, extracellular matrix engineering, and bioactive scaffolds have enabled the development of the next generation of biological implants.

Biological Implants Market- Segmentation Analysis:

The Global Biological Implants Market is segmented on the basis of Graft, Procedure Type, Application, End User, and Region.

In terms of product segmentation, allografts represent a significant portion of biological implants because of their extensive clinical application in orthopedic, dental, cardiovascular, and reconstructive surgeries. The advantage of using allografts lies in their ability to avoid additional wound in the donor area like in the case of autografts, which helps to reduce donor-site complications and deliver effective support and regrowth of the tissue. Improvements in tissue banking, sterilization techniques, and donor evaluation have made allografts even safer to use. As reported by the U.S. Health Resources and Services Administration (HRSA), more than 1 million tissue transplantations are conducted yearly in the United States, involving bone, tendons, skin, heart valves, and corneas.

Based on application segment, the largest share of the biological implants market is held by orthopedics due to an increasing prevalence of musculoskeletal diseases, osteoporosis, fractures, sports injuries, and degenerative joint diseases. WHO estimates that around 1.71 billion people all over the world suffer from musculoskeletal diseases and are the major cause of disabilities among all. The number of procedures such as spinal fusion, bone repair, joint replacement, ligament repair is growing continuously which results in an increased use of biological bone and tendon grafts. Moreover, the cardiovascular segment also holds a large share due to 17.9 million yearly death cases due to cardiovascular diseases. However, the adoption of biological implants in the segments such as dentistry, wound care, reconstructive surgery, ophthalmology, hernia repair, and sports medicine are rapidly growing due to their high biocompatibility and regenerative characteristics.

Biological Implants Market- Geographical Insights

The Biological Implants Market is dominated by North America owing to the region's sophisticated healthcare sector, substantial healthcare spending, well-developed tissue banking system, favorable reimbursement policies, and rapid adoption of regenerative technology. The North American region undertakes a wide number of orthopedic, cardiovascular, reconstructive, dental, and wound care surgeries every year, creating steady demand for biological implants. The CDC reports that around three out of four adults in the U.S. suffer from at least one chronic disease, while half of the adults in the country are affected by two or more chronic diseases. Among people aged above 65 years in the country, around 90 percent suffer from at least one chronic disease, which is greater than 75 percent among those aged between 35 years and 64 years and over 60 percent of those aged between 18 years and 34 years. The rising prevalence of various chronic diseases, including cardiovascular diseases, arthritis, diabetes, and obesity, creates increasing demand for biologic grafts, regenerative implants, and tissue-based therapies.

Europe is a notable contributor to the global Biological Implants Market due to the increase in spending on health care, positive regulatory environment, presence of advanced tissue banking facilities, and greater investments in regenerative medicine. The European Commission has stated that there are 3,492 licensed tissue establishments within Europe Union Member States to ensure the proper collection, processing, storage, and distribution of human tissues and cells used for transplantation and biological implants procedures. These facilities facilitate the use of biologic implants on a large scale. Moreover, the increased preference for minimally invasive surgical procedures, rise in orthopedic and cardiovascular surgeries, and growing demand for biological heart valves and soft tissue reconstructive products have been fueling the market growth with Germany, France, the UK, Italy, and Spain being the leaders in the region because of well-established healthcare infrastructure and biomedical research.

Biological Implants Market- Competitive Landscape:

The biological implants market enjoys fierce competition due to the existence of well-established firms producing medical devices, regenerative medicines and biomaterials with a wide array of biological grafts, acellular dermal matrices, collagen implants, biologic meshes and tissue engineering devices. Firms such as Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., Edwards Lifesciences Corporation and Smith+Nephew plc enjoy dominant positions in the industry thanks to their extensive product lines, international distribution channels, product innovation and investments in regenerative medicine, tissue engineering and biomaterial science.

According to NIH National Library of Medicine, more than 100,000 ACL reconstructive surgeries are done every year in the United States, out of which many surgeries employ biological implants like autografts and allografts in ligament reconstruction surgeries. The growing number of sports injuries and orthopedic diseases has continued to fuel the demand for innovative biological grafts and regenerative implants. Specialized firms such as LifeNet Health, MTF Biologics, Organogenesis Holdings Inc., Integra LifeSciences Holdings Corporation, and Cook Biotech Incorporated have helped increase market competition with the availability of allografts, xenografts, ECM products, and collagen-based regenerative products for orthopedic, cardiovascular, wound management, reconstructive, and sports medicine indications.

Recent Developments:

In February2026, CollPlant launched BioFlex, a ready-to-print rhCollagen-based kit for Digital Light Processing (DLP) 3D bioprinting. Designed for academic and industrial research, the platform supported the biofabrication of advanced tissue models, engineered tissues, and potential transplantable organs, strengthening the company's portfolio in tissue engineering, regenerative medicine, and biological biomaterials.

In March 2025, Cellino and Matricelf announced a strategic collaboration to accelerate the global biomanufacturing of personalized spinal cord injury treatments. The partnership combined Cellino's Nebula(TM) automated induced pluripotent stem cell (iPSC) manufacturing platform with Matricelf's double autologous 3D differentiation technology to advance scalable, patient-specific regenerative therapies for spinal cord repair.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOLOGICAL IMPLANTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Medtronic plc
• Johnson & Johnson - DePuy Synthes
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Smith+Nephew plc
• Edwards Lifesciences Corporation
• Baxter International Inc.
• Integra LifeSciences Holdings Corporation
• Organogenesis Holdings Inc.
• MTF Biologics
• LifeNet Health
• RTI Surgical
• Orthofix Medical Inc.
• Globus Medical, Inc.
• AbbVie Inc. - LifeCell
• Vericel Corporation
• MiMedx Group, Inc.
• Elutia Inc.
• Cook Biotech Incorporated*
• Geistlich Pharma AG
• CollPlant Biotechnologies Ltd.
• Bioventus Inc.
• CONMED Corporation
• Artivion, Inc.
• LeMaitre Vascular, Inc.
• Abbott Laboratories
• B. Braun SE
• Coloplast A/S
• Straumann Holding AG
• Dentsply Sirona Inc.
• Xtant Medical Holdings, Inc.
• Others

GLOBAL BIOLOGICAL IMPLANTS MARKET, BY GRAFT - MARKET ANALYSIS, 2020 - 2033

• Autografts
• Allografts
• Xenografts
• Bioengineered/Tissue-Engineered Implants
• Others

GLOBAL BIOLOGICAL IMPLANTS MARKET, BY PROCEDURE TYPE - MARKET ANALYSIS, 2020 - 2033

• Open Surgical Implantation
• Minimally Invasive Implantation
• Percutaneous/Injectable Delivery
• Others

GLOBAL BIOLOGICAL IMPLANTS MARKET, BY APPLICATION - MARKET ANALYSIS, 2020 - 2033

• Orthopedics and Spine
• Bone Reconstruction and Fusion
• Joint and Cartilage Repair
• Sports Medicine
• Cardiovascular
• Dental and Maxillofacial
• Wound Care
• Plastic and Reconstructive Surgery
• Hernia and Soft-Tissue Repair
• Ophthalmology
• Others

GLOBAL BIOLOGICAL IMPLANTS MARKET, BY END USER - MARKET ANALYSIS, 2020 - 2033

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Dental Clinics
• Research & Academic Institutes
• Others

GLOBAL BIOLOGICAL IMPLANTS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Denmark
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Taiwan
• Vietnam
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Iran
• Qatar
• Rest of MEA

Table of Contents

1. Biological Implants Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Biological Implants Market Snippet by Graft
  • 2.1.2. Biological Implants Market Snippet by Procedure Type
  • 2.1.3. Biological Implants Market Snippet by Application
  • 2.1.4. Biological Implants Market Snippet by End User
  • 2.1.5. Biological Implants Market Snippet by Country
  • 2.1.6. Biological Implants Market Snippet by Region
• 2.2. Competitive Insights

3. Biological Implants Key Market Trends

• 3.1. Biological Implants Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Biological Implants Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Biological Implants Market Opportunities
• 3.4. Biological Implants Market Future Trends

4. Biological Implants Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Biological Implants Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Biological Implants Market Landscape

• 6.1. Biological Implants Market Share Analysis, 2025
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Biological Implants Market - By Graft

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Graft, 2025 & 2033 (%)
  • 7.1.2. Autografts
  • 7.1.3. Allografts
  • 7.1.4. Xenografts
  • 7.1.5. Bioengineered/Tissue-Engineered Implants
  • 7.1.6. Others

8. Biological Implants Market - By Procedure Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Procedure Type, 2025 & 2033 (%)
  • 8.1.2. Open Surgical Implantation
  • 8.1.3. Minimally Invasive Implantation
  • 8.1.4. Percutaneous/Injectable Delivery
  • 8.1.5. Others

9. Biological Implants Market - By Application

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
  • 9.1.2. Orthopedics and Spine
    • 9.1.2.1. Bone Reconstruction and Fusion
    • 9.1.2.2. Joint and Cartilage Repair
    • 9.1.2.3. Sports Medicine
  • 9.1.3. Cardiovascular
  • 9.1.4. Dental and Maxillofacial
  • 9.1.5. Wound Care
  • 9.1.6. Plastic and Reconstructive Surgery
  • 9.1.7. Hernia and Soft-Tissue Repair
  • 9.1.8. Ophthalmology
  • 9.1.9. Others

10. Biological Implants Market - By End User

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By Procedure Type, 2025 & 2033 (%)
  • 10.1.2. Hospitals
  • 10.1.3. Ambulatory Surgical Centers (ASCs)
  • 10.1.4. Specialty Clinics
  • 10.1.5. Dental Clinics
  • 10.1.6. Research & Academic Institutes
  • 10.1.7. Others

11. Biological Implants Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Biological Implants Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Biological Implants Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.9. UK
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.9.3. UK Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.3.9.4. UK Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.10. France
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.10.3. France Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.3.10.4. France Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.11. Italy
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.11.3. Italy Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.3.11.4. Italy Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.12. Spain
    • 11.3.12.1. Overview
    • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.12.3. Spain Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.3.12.4. Spain Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.13. The Netherlands
    • 11.3.13.1. Overview
    • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.13.3. The Netherlands Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.3.13.4. The Netherlands Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Overview
    • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.15. Russia
    • 11.3.15.1. Overview
    • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.15.3. Russia Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.3.15.4. Russia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.16. Poland
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.16.3. Poland Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.3.16.4. Poland Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.17. Denmark
    • 11.3.17.1. Overview
    • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.17.3. Poland Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.3.17.4. Denmark Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.17.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.18. Rest of Europe
    • 11.3.18.1. Overview
    • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Biological Implants Key Manufacturers in Asia Pacific
  • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.4.4. APAC Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
  • 11.4.5. APAC Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
  • 11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.8. China
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.8.3. China Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.4.8.4. China Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.9. India
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.9.3. India Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.4.9.4. India Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.13. Indonesia
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.13.3. Indonesia Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.4.13.4. Indonesia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.14. Thailand
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.14.3. Thailand Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.4.14.4. Thailand Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.16. Taiwan
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.16.3. Taiwan Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.4.16.4. Taiwan Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.16.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.17. Vietnam
    • 11.4.17.1. Overview
    • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.17.3. Vietnam Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.4.17.4. Vietnam Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.17.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.18. Rest of APAC
    • 11.4.18.1. Overview
    • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.18.3. Rest of APAC Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.4.18.4. Rest of APAC Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.18.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 11.5. Latin America (LATAM)
  • 11.5.1. Overview
  • 11.5.2. Biological Implants Key Manufacturers in Latin America
  • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.5.4. LATAM Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
  • 11.5.5. LATAM Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
  • 11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 11.6. Middle East and Africa (MEA)
  • 11.6.1. Overview
  • 11.6.2. Biological Implants Key Manufacturers in Middle East and Africa
  • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.6.4. MEA Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
  • 11.6.5. MEA Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
  • 11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.14. Iran
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.14.3. Iran Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.6.14.4. Iran Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.14.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.15. Qatar
    • 11.6.15.1. Overview
    • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.15.3. Qatar Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.6.15.4. Qatar Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.15.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.16. Rest of MEA
    • 11.6.16.1. Overview
    • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.16.3. Rest of MEA Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.6.16.4. Rest of MEA Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.16.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Biological Implants Industry

• 12.1. Competitive Benchmarking
  • 12.1.1. Competitive Dashboard
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. Medtronic plc
  • 12.2.2. Johnson & Johnson - DePuy Synthes
  • 12.2.3. Stryker Corporation
  • 12.2.4. Zimmer Biomet Holdings, Inc.
  • 12.2.5. Smith+Nephew plc
  • 12.2.6. Edwards Lifesciences Corporation
  • 12.2.7. Baxter International Inc.
  • 12.2.8. Integra LifeSciences Holdings Corporation
  • 12.2.9. Organogenesis Holdings Inc.
  • 12.2.10. MTF Biologics
  • 12.2.11. LifeNet Health
  • 12.2.12. RTI Surgical
  • 12.2.13. Orthofix Medical Inc.
  • 12.2.14. Globus Medical, Inc.
  • 12.2.15. AbbVie Inc. - LifeCell
  • 12.2.16. Vericel Corporation
  • 12.2.17. MiMedx Group, Inc.
  • 12.2.18. Elutia Inc.
  • 12.2.19. Cook Biotech Incorporated*
  • 12.2.20. Geistlich Pharma AG
  • 12.2.21. CollPlant Biotechnologies Ltd.
  • 12.2.22. Bioventus Inc.
  • 12.2.23. CONMED Corporation
  • 12.2.24. Artivion, Inc.
  • 12.2.25. LeMaitre Vascular, Inc.
  • 12.2.26. Abbott Laboratories
  • 12.2.27. B. Braun SE
  • 12.2.28. Coloplast A/S
  • 12.2.29. Straumann Holding AG
  • 12.2.30. Dentsply Sirona Inc.
  • 12.2.31. Xtant Medical Holdings, Inc.
  • 12.2.32. Others

13. 360 Degree AnalystView

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us